UNC5B and ischemia: To gain further insight into the potential role of UNC5B as a therapeutic target we administered 2.5 μg antibody at time point of ischemia and following reperfusion in 100 μl PBS against UNC5B per mouse (WT+UNC5B-AB) 30 minutes prior to ischemia.